Revvity Inc
Veridion Score
Composite trend over time
Why is RVTY moving today?
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for RVTY.
RVTY insider activity
Revvity Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$2.4M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | 2026-04-20 | Gonzales Anita | Insider | sell | $92.80 | 80 | 7,319 | $7K | SEC Form 4 |
| 2026-02-26 | 2026-02-24 | Victor Miriame | Insider | sell | $97.13 | 1,862 | 18,122 | $181K | SEC Form 4 |
| 2026-02-26 | 2026-02-24 | Victor Miriame | Insider | buy | $95.74 | 1,862 | 19,984 | $178K | SEC Form 4 |
| 2026-02-25 | 2026-02-23 | McMurry-Heath Michelle | Insider | sell | $97.26 | 600 | 4,233 | $58K | SEC Form 4 |
| 2026-02-19 | 2026-02-17 | Gonzales Anita | Insider | sell | $96.03 | 85 | 4,078 | $8K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 30 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moRVTY contract awards, year to date.
Public federal awards linked to this ticker.
RVTY lobbying filings, year to date.
Registered lobbying filings matched to Revvity Inc.